GO Term |
GO Name |
Enriched Genes |
Log10 Adjusted P-value |
[BP] GO:0008152 |
metabolic process
|
ACHE, AKR1B1, AKR1B10, ALOX15, ALPL, AOX1, BCL2, CA1, CA12, CA2, CA4, CA6, CA7, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, FUT7, GBA2, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSPA1A, IGF1R, INSR, KDR, MET, MMP1, MMP2, MMP9, NUAK1, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2, TYR, XDH |
9.27485 |
[BP] GO:0010647 |
positive regulation of cell communication
|
AKR1B1, ALOX15, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, EGFR, F10, F3, GPR35, HSPA1A, INSR, KDR, MET, MMP9, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2, XDH |
8.02008 |
[BP] GO:0010033 |
response to organic substance
|
AKR1B1, ALOX15, ALPL, BCL2, CA2, CDK6, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, EGFR, ESR1, ESRRA, FABP3, FABP4, HSD11B2, HSD17B2, HSPA1A, IGF1R, INSR, KDR, MMP2, SMAD3, SRC, TEK, TYR |
8.02008 |
[BP] GO:0023056 |
positive regulation of signaling
|
AKR1B1, ALOX15, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, EGFR, F10, F3, GPR35, HSPA1A, INSR, KDR, MET, MMP9, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2, XDH |
8.02008 |
[BP] GO:0008202 |
steroid metabolic process
|
AKR1B1, AKR1B10, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, GBA2, HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
8.02008 |
[BP] GO:0065008 |
regulation of biological quality
|
ACHE, AKR1B1, ALOX15, BCL2, CA12, CA2, CA7, CDK6, CYP19A1, CYP1A1, CYP1B1, EGFR, ESR1, F10, F3, FABP3, FABP4, GPR35, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSPA1A, INSR, KDR, MET, SMAD3, SRC, TEK, TNKS, TNKS2, XDH |
7.60518 |
[BP] GO:1901700 |
response to oxygen-containing compound
|
AKR1B1, ALPL, BCL2, CDK6, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, EGFR, ESR1, ESRRA, FABP3, HSD11B2, HSD17B2, IGF1R, INSR, MMP2, MMP9, SRC, TEK, TYR |
7.52046 |
[BP] GO:0044237 |
cellular metabolic process
|
ACHE, AKR1B1, AKR1B10, ALOX15, ALPL, AOX1, BCL2, CA1, CA12, CA2, CA4, CA6, CA7, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F10, FABP3, FABP4, FUT7, GBA2, HSD17B1, HSD17B2, HSPA1A, IGF1R, INSR, KDR, MET, MMP1, MMP2, NUAK1, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2, TYR, XDH |
7.29823 |
[BP] GO:0015701 |
bicarbonate transport
|
CA1, CA12, CA14, CA2, CA4, CA6, CA7 |
7.21873 |
[BP] GO:0006629 |
lipid metabolic process
|
ACHE, AKR1B1, AKR1B10, ALOX15, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, EGFR, ESR1, FABP3, FABP4, FUT7, GBA2, HSD11B1, HSD11B2, HSD17B1, HSD17B2, MET |
7.15021 |
[BP] GO:0042221 |
response to chemical
|
AKR1B1, ALOX15, ALPL, BCL2, CA2, CDK6, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, EGFR, ESR1, ESRRA, FABP3, FABP4, HSD11B2, HSD17B2, HSPA1A, IGF1R, INSR, KDR, MMP2, MMP9, SMAD3, SRC, TEK, TYR |
6.95026 |
[BP] GO:0042445 |
hormone metabolic process
|
ACHE, AKR1B1, CYP19A1, CYP1A1, CYP1B1, ESR1, HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
6.86167 |
[BP] GO:0019748 |
secondary metabolic process
|
AKR1B1, AKR1B10, BCL2, CYP1A1, CYP1A2, CYP1B1, TYR |
6.86167 |
[BP] GO:0048522 |
positive regulation of cellular process
|
ACHE, AKR1B1, ALOX15, BCL2, CA2, CA7, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, GPR35, HSPA1A, IGF1R, INSR, KDR, MET, MMP1, MMP2, MMP9, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2, XDH |
6.77808 |
[BP] GO:0042127 |
regulation of cell proliferation
|
AKR1B1, BCL2, CDC25B, CDK6, CSNK2A1, CYP1B1, EGFR, ESR1, ESRRA, F3, FABP3, HSPA1A, IGF1R, INSR, KDR, MMP2, MMP9, NUAK1, SMAD3, SRC, TEK, XDH |
6.67467 |
[BP] GO:0048513 |
animal organ development
|
ACHE, BCL2, CA2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, EGFR, ESR1, ESRRA, ESRRB, HSD11B1, HSD17B2, INSR, KDR, SMAD3, SRC, TEK, TYR |
6.51856 |
[BP] GO:0009967 |
positive regulation of signal transduction
|
AKR1B1, ALOX15, BCL2, CSNK2A1, CYP1B1, EGFR, F10, F3, GPR35, HSPA1A, INSR, KDR, MET, MMP9, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2, XDH |
6.46612 |
[BP] GO:0010646 |
regulation of cell communication
|
ACHE, AKR1B1, ALOX15, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DUSP3, EGFR, ESR1, ESR2, F10, F3, GPR35, HSPA1A, IGF1R, INSR, KDR, MET, MMP9, NUAK1, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2, XDH |
6.29613 |
[BP] GO:0006730 |
one-carbon metabolic process
|
CA1, CA12, CA2, CA4, CA6, CA7 |
6.19994 |
[BP] GO:0023051 |
regulation of signaling
|
ACHE, AKR1B1, ALOX15, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DUSP3, EGFR, ESR1, ESR2, F10, F3, GPR35, HSPA1A, IGF1R, INSR, KDR, MET, MMP9, NUAK1, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2, XDH |
6.19994 |
[BP] GO:0033993 |
response to lipid
|
ALPL, BCL2, CA2, CDK6, CSNK2A1, CYP1A1, CYP1A2, EGFR, ESR1, ESRRA, FABP3, HSD11B2, HSD17B2, SRC, TYR |
6.10922 |
[BP] GO:0009719 |
response to endogenous stimulus
|
AKR1B1, ALPL, BCL2, CA2, CSNK2A1, CYP1A2, EGFR, ESR1, ESRRA, FABP3, HSD11B2, IGF1R, INSR, MMP2, SMAD3, SRC, TEK |
6.10922 |
[BP] GO:0048518 |
positive regulation of biological process
|
ACHE, AKR1B1, ALOX15, BCL2, CA2, CA7, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, GPR35, HSPA1A, IGF1R, INSR, KDR, MET, MMP1, MMP2, MMP9, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2, XDH |
6.10922 |
[BP] GO:0048584 |
positive regulation of response to stimulus
|
AKR1B1, ALOX15, BCL2, CSNK2A1, CYP1B1, EGFR, ESRRA, F10, F3, FABP4, GPR35, HSPA1A, INSR, KDR, MET, MMP2, MMP9, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2, XDH |
6.05932 |
[BP] GO:1902531 |
regulation of intracellular signal transduction
|
AKR1B1, ALOX15, BCL2, CSNK2A1, CYP1B1, DUSP3, EGFR, ESR1, F10, F3, GPR35, HSPA1A, IGF1R, INSR, KDR, MET, MMP9, NUAK1, PTPN1, SRC, TEK, XDH |
5.98358 |
[BP] GO:0044238 |
primary metabolic process
|
ACHE, AKR1B1, AKR1B10, ALOX15, ALPL, AOX1, BCL2, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, FUT7, GBA2, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSPA1A, IGF1R, INSR, KDR, MET, MMP1, MMP2, MMP9, NUAK1, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2, TYR, XDH |
5.9518 |
[BP] GO:0009725 |
response to hormone
|
AKR1B1, ALPL, BCL2, CA2, CSNK2A1, CYP1A2, EGFR, ESR1, ESRRA, FABP3, HSD11B2, INSR, SRC, TEK |
5.70605 |
[BP] GO:0030335 |
positive regulation of cell migration
|
BCL2, EGFR, F10, F3, IGF1R, INSR, KDR, MET, MMP9, SMAD3, SRC, TEK |
5.7011 |
[BP] GO:2000147 |
positive regulation of cell motility
|
BCL2, EGFR, F10, F3, IGF1R, INSR, KDR, MET, MMP9, SMAD3, SRC, TEK |
5.55213 |
[BP] GO:0010035 |
response to inorganic substance
|
AKR1B1, ALOX15, BCL2, CA2, CYP1A1, CYP1A2, CYP1B1, EGFR, FABP4, KDR, MMP9, SRC |
5.52148 |
[BP] GO:2000145 |
regulation of cell motility
|
BCL2, CDK6, CYP19A1, CYP1B1, EGFR, F10, F3, IGF1R, INSR, KDR, MET, MMP9, SMAD3, SRC, TEK |
5.46835 |
[BP] GO:0051272 |
positive regulation of cellular component movement
|
BCL2, EGFR, F10, F3, IGF1R, INSR, KDR, MET, MMP9, SMAD3, SRC, TEK |
5.45018 |
[BP] GO:1902533 |
positive regulation of intracellular signal transduction
|
AKR1B1, ALOX15, BCL2, CYP1B1, EGFR, F10, F3, GPR35, HSPA1A, INSR, KDR, MET, PTPN1, SRC, TEK, XDH |
5.38689 |
[BP] GO:0040017 |
positive regulation of locomotion
|
BCL2, EGFR, F10, F3, IGF1R, INSR, KDR, MET, MMP9, SMAD3, SRC, TEK |
5.29987 |
[BP] GO:0014070 |
response to organic cyclic compound
|
ALPL, BCL2, CA2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, EGFR, ESR1, ESRRA, HSD11B2, SRC, TEK, TYR |
5.27411 |
[BP] GO:0048583 |
regulation of response to stimulus
|
AKR1B1, ALOX15, BCL2, CDK6, CSNK2A1, CYP19A1, CYP1B1, DUSP3, EGFR, ESR1, ESR2, ESRRA, F10, F3, FABP4, GPR35, HSPA1A, IGF1R, INSR, KDR, MET, MMP2, MMP9, NUAK1, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2, XDH |
5.27411 |
[BP] GO:0070887 |
cellular response to chemical stimulus
|
AKR1B1, ALOX15, ALPL, BCL2, CDK6, CYP1A1, CYP1A2, CYP1B1, EGFR, ESR1, FABP4, HSPA1A, IGF1R, INSR, KDR, MMP2, MMP9, SMAD3, SRC |
5.24142 |
[BP] GO:0071704 |
organic substance metabolic process
|
ACHE, AKR1B1, AKR1B10, ALOX15, ALPL, AOX1, BCL2, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, FUT7, GBA2, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSPA1A, IGF1R, INSR, KDR, MET, MMP1, MMP2, MMP9, NUAK1, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2, TYR, XDH |
5.24014 |
[BP] GO:0040012 |
regulation of locomotion
|
BCL2, CDK6, CYP19A1, CYP1B1, EGFR, F10, F3, IGF1R, INSR, KDR, MET, MMP9, SMAD3, SRC, TEK |
5.09775 |
[BP] GO:0051270 |
regulation of cellular component movement
|
BCL2, CDK6, CYP19A1, CYP1B1, EGFR, F10, F3, IGF1R, INSR, KDR, MET, MMP9, SMAD3, SRC, TEK |
5.08731 |
[BP] GO:0042446 |
hormone biosynthetic process
|
AKR1B1, CYP19A1, HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
5.06412 |
[BP] GO:0044281 |
small molecule metabolic process
|
AKR1B1, AKR1B10, ALOX15, AOX1, CA1, CA12, CA2, CA4, CA6, CA7, CYP19A1, CYP1A1, CYP1A2, CYP1B1, FABP3, FUT7, GBA2, HSPA1A, TYR, XDH |
5.05009 |
[BP] GO:0034754 |
cellular hormone metabolic process
|
AKR1B1, CYP19A1, CYP1A1, CYP1B1, ESR1, HSD17B1, HSD17B2 |
5.03026 |
[BP] GO:0030334 |
regulation of cell migration
|
BCL2, CYP19A1, CYP1B1, EGFR, F10, F3, IGF1R, INSR, KDR, MET, MMP9, SMAD3, SRC, TEK |
5.03026 |
[BP] GO:0048856 |
anatomical structure development
|
ACHE, AKR1B1, ALOX15, ALPL, BCL2, CA2, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DUSP3, EGFR, ESR1, ESRRA, ESRRB, GBA2, HSD11B1, HSD17B2, INSR, KDR, MMP9, SMAD3, SRC, TEK, TYR |
4.97861 |
[BP] GO:0032501 |
multicellular organismal process
|
AKR1B1, AKR1B10, ALOX15, ALPL, BCL2, CYP19A1, CYP1A2, CYP1B1, DUSP3, EGFR, ESR1, ESRRB, F10, F3, FABP4, HSD11B2, HSD17B2, IGF1R, INSR, MET, MMP1, MMP2, MMP9, SMAD3, SRC, TEK, TNKS2, TYR |
4.97861 |
[BP] GO:0032502 |
developmental process
|
ACHE, AKR1B1, ALOX15, ALPL, BCL2, CA2, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DUSP3, EGFR, ESR1, ESRRA, ESRRB, FABP4, FUT7, GBA2, HSD11B1, HSD17B2, INSR, KDR, MET, MMP2, MMP9, SMAD3, SRC, TEK, TNKS2, TYR |
4.9214 |
[BP] GO:0001503 |
ossification
|
ALOX15, ALPL, BCL2, EGFR, MMP2, MMP9, TEK |
4.90356 |
[BP] GO:0009966 |
regulation of signal transduction
|
AKR1B1, ALOX15, BCL2, CSNK2A1, CYP1B1, DUSP3, EGFR, ESR1, ESR2, F10, F3, GPR35, HSPA1A, IGF1R, INSR, KDR, MET, MMP9, NUAK1, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2, XDH |
4.69823 |
[BP] GO:0032847 |
regulation of cellular pH reduction
|
BCL2, CA2, CA7 |
4.49966 |
[BP] GO:1901564 |
organonitrogen compound metabolic process
|
ACHE, AKR1B1, ALPL, AOX1, BCL2, CDC25B, CDK6, CSNK2A1, CYP1A1, CYP1A2, DUSP3, EGFR, ESR1, F10, F3, FUT7, GBA2, HSPA1A, IGF1R, INSR, KDR, MET, MMP1, MMP2, MMP9, NUAK1, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2, TYR, XDH |
4.43931 |
[BP] GO:0010638 |
positive regulation of organelle organization
|
ALOX15, BCL2, HSPA1A, INSR, KDR, MET, MMP9, SMAD3, SRC, TEK, TNKS, TNKS2 |
4.37619 |
[BP] GO:0008284 |
positive regulation of cell proliferation
|
AKR1B1, BCL2, CDC25B, CDK6, CSNK2A1, EGFR, ESR1, F3, IGF1R, INSR, KDR, MMP2, MMP9, TEK |
4.37619 |
[BP] GO:0051896 |
regulation of protein kinase B signaling
|
EGFR, F10, F3, INSR, MET, SRC, TEK, XDH |
4.3382 |
[BP] GO:0055114 |
oxidation-reduction process
|
AKR1B1, AKR1B10, ALOX15, AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, HSD11B1, HSD11B2, HSD17B1, HSD17B2, TYR, XDH |
4.32368 |
[BP] GO:0010817 |
regulation of hormone levels
|
ACHE, AKR1B1, CYP19A1, CYP1A1, CYP1B1, EGFR, ESR1, HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
4.29617 |
[BP] GO:0071310 |
cellular response to organic substance
|
AKR1B1, ALOX15, ALPL, BCL2, CDK6, CYP1A1, CYP1B1, EGFR, ESR1, FABP4, IGF1R, INSR, KDR, MMP2, SMAD3, SRC |
4.2879 |
[BP] GO:0006796 |
phosphate-containing compound metabolic process
|
ACHE, ALOX15, ALPL, BCL2, CDC25B, CDK6, CSNK2A1, DUSP3, EGFR, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PTPN1, SRC, TEK, TNKS, XDH |
4.23063 |
[BP] GO:0038083 |
peptidyl-tyrosine autophosphorylation
|
EGFR, IGF1R, INSR, KDR, SRC |
4.18171 |
[BP] GO:0051897 |
positive regulation of protein kinase B signaling
|
EGFR, F10, F3, INSR, MET, SRC, TEK |
4.14417 |
[BP] GO:0032879 |
regulation of localization
|
ACHE, ALOX15, BCL2, CA2, CA7, CDK6, CSNK2A1, CYP19A1, CYP1B1, EGFR, F10, F3, GPR35, HSPA1A, IGF1R, INSR, KDR, MET, MMP9, PTPN1, SMAD3, SRC, TEK |
4.109 |
[BP] GO:0080134 |
regulation of response to stress
|
CDK6, CYP19A1, DUSP3, EGFR, ESR1, F3, FABP4, HSPA1A, IGF1R, MET, MMP2, NUAK1, PTPN1, SMAD3, SRC, TEK, XDH |
3.99705 |
[BP] GO:0006793 |
phosphorus metabolic process
|
ACHE, ALOX15, ALPL, BCL2, CDC25B, CDK6, CSNK2A1, DUSP3, EGFR, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PTPN1, SRC, TEK, TNKS, XDH |
3.94771 |
[BP] GO:0048585 |
negative regulation of response to stimulus
|
ALOX15, BCL2, CDK6, CYP19A1, DUSP3, EGFR, ESR1, ESR2, HSPA1A, IGF1R, MET, MMP9, PTPN1, SMAD3, SRC, TEK, XDH |
3.90831 |
[BP] GO:0001952 |
regulation of cell-matrix adhesion
|
BCL2, CDK6, KDR, SMAD3, SRC, TEK |
3.89716 |
[BP] GO:0008210 |
estrogen metabolic process
|
CYP19A1, CYP1B1, HSD17B1, HSD17B2 |
3.79835 |
[BP] GO:0043067 |
regulation of programmed cell death
|
AKR1B1, BCL2, CSNK2A1, CYP1B1, EGFR, ESR1, F3, HSPA1A, IGF1R, KDR, MET, MMP9, PTPN1, SMAD3, SRC, TEK, XDH |
3.79161 |
[BP] GO:0051130 |
positive regulation of cellular component organization
|
ALOX15, BCL2, ESR1, HSPA1A, IGF1R, INSR, KDR, MET, MMP1, MMP9, SMAD3, SRC, TEK, TNKS, TNKS2 |
3.78887 |
[BP] GO:0043069 |
negative regulation of programmed cell death
|
AKR1B1, BCL2, CSNK2A1, EGFR, HSPA1A, IGF1R, KDR, MET, MMP9, PTPN1, SMAD3, SRC, TEK |
3.72954 |
[BP] GO:0019220 |
regulation of phosphate metabolic process
|
ALOX15, BCL2, CDC25B, DUSP3, EGFR, ESRRB, FABP3, FABP4, IGF1R, INSR, KDR, MMP9, NUAK1, PTPN1, SMAD3, SRC, TEK, XDH |
3.70377 |
[BP] GO:0051174 |
regulation of phosphorus metabolic process
|
ALOX15, BCL2, CDC25B, DUSP3, EGFR, ESRRB, FABP3, FABP4, IGF1R, INSR, KDR, MMP9, NUAK1, PTPN1, SMAD3, SRC, TEK, XDH |
3.66751 |
[BP] GO:0050896 |
response to stimulus
|
ACHE, AKR1B1, ALOX15, ALPL, BCL2, CA2, CA6, CDK6, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, EGFR, ESR1, ESRRA, F10, F3, FABP3, FABP4, HSD11B2, HSD17B2, HSPA1A, IGF1R, INSR, KDR, MMP2, MMP9, NUAK1, PTPN1, SMAD3, SRC, TEK, TYR |
3.66329 |
[BP] GO:0018108 |
peptidyl-tyrosine phosphorylation
|
EGFR, IGF1R, INSR, KDR, MET, SRC, TEK |
3.65189 |
[BP] GO:0010810 |
regulation of cell-substrate adhesion
|
ALOX15, BCL2, CDK6, KDR, SMAD3, SRC, TEK |
3.63008 |
[BP] GO:0018212 |
peptidyl-tyrosine modification
|
EGFR, IGF1R, INSR, KDR, MET, SRC, TEK |
3.61923 |
[BP] GO:0051716 |
cellular response to stimulus
|
AKR1B1, ALOX15, ALPL, BCL2, CA2, CDK6, CYP1A1, CYP1A2, CYP1B1, EGFR, ESR1, FABP4, HSPA1A, IGF1R, INSR, KDR, MMP2, MMP9, NUAK1, PTPN1, SMAD3, SRC |
3.57684 |
[BP] GO:0007169 |
transmembrane receptor protein tyrosine kinase signaling pathway
|
EGFR, IGF1R, INSR, KDR, MET, MMP2, MMP9, PTPN1, SRC, TEK |
3.55739 |
[BP] GO:0046777 |
protein autophosphorylation
|
CSNK2A1, EGFR, IGF1R, INSR, KDR, SRC, TEK |
3.53582 |
[BP] GO:0006694 |
steroid biosynthetic process
|
AKR1B1, CYP19A1, HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
3.483 |
[BP] GO:0006468 |
protein phosphorylation
|
BCL2, CDC25B, CDK6, CSNK2A1, EGFR, IGF1R, INSR, KDR, MET, NUAK1, SRC, TEK, TNKS |
3.44319 |
[BP] GO:1902532 |
negative regulation of intracellular signal transduction
|
BCL2, DUSP3, ESR1, HSPA1A, IGF1R, MET, MMP9, PTPN1, SRC, XDH |
3.44284 |
[BP] GO:0009056 |
catabolic process
|
ACHE, AKR1B10, AOX1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, FABP3, FABP4, FUT7, GBA2, HSPA1A, MMP1, MMP2, MMP9, SRC, XDH |
3.44284 |
[BP] GO:0010941 |
regulation of cell death
|
AKR1B1, BCL2, CSNK2A1, CYP1B1, EGFR, ESR1, F3, HSPA1A, IGF1R, KDR, MET, MMP9, PTPN1, SMAD3, SRC, TEK, XDH |
3.44284 |
[BP] GO:0010562 |
positive regulation of phosphorus metabolic process
|
ALOX15, BCL2, CDC25B, EGFR, ESRRB, FABP3, INSR, KDR, MMP9, PTPN1, SMAD3, SRC, TEK, XDH |
3.44284 |
[BP] GO:0045937 |
positive regulation of phosphate metabolic process
|
ALOX15, BCL2, CDC25B, EGFR, ESRRB, FABP3, INSR, KDR, MMP9, PTPN1, SMAD3, SRC, TEK, XDH |
3.44284 |
[BP] GO:0051173 |
positive regulation of nitrogen compound metabolic process
|
ALOX15, BCL2, CDC25B, CSNK2A1, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, HSPA1A, IGF1R, INSR, KDR, MET, MMP9, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2, XDH |
3.43968 |
[BP] GO:0048878 |
chemical homeostasis
|
AKR1B1, BCL2, CA12, CA2, CA7, EGFR, ESR1, FABP3, FABP4, GPR35, INSR, MET, SMAD3 |
3.43505 |
[BP] GO:0010648 |
negative regulation of cell communication
|
ACHE, BCL2, DUSP3, EGFR, ESR1, ESR2, GPR35, HSPA1A, IGF1R, MET, MMP9, PTPN1, SMAD3, SRC, XDH |
3.41277 |
[BP] GO:0060548 |
negative regulation of cell death
|
AKR1B1, BCL2, CSNK2A1, EGFR, HSPA1A, IGF1R, KDR, MET, MMP9, PTPN1, SMAD3, SRC, TEK |
3.40739 |
[BP] GO:0023057 |
negative regulation of signaling
|
ACHE, BCL2, DUSP3, EGFR, ESR1, ESR2, GPR35, HSPA1A, IGF1R, MET, MMP9, PTPN1, SMAD3, SRC, XDH |
3.40375 |
[BP] GO:1901615 |
organic hydroxy compound metabolic process
|
AKR1B1, AKR1B10, ALOX15, BCL2, CYP19A1, CYP1A1, CYP1B1, GBA2, TYR |
3.3538 |
[BP] GO:0044255 |
cellular lipid metabolic process
|
ACHE, AKR1B10, ALOX15, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, EGFR, FABP3, FABP4, FUT7, GBA2, MET |
3.3538 |
[BP] GO:0007167 |
enzyme linked receptor protein signaling pathway
|
EGFR, IGF1R, INSR, KDR, MET, MMP2, MMP9, PTPN1, SMAD3, SRC, TEK |
3.31784 |
[BP] GO:0097267 |
omega-hydroxylase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1 |
3.31784 |
[BP] GO:0042981 |
regulation of apoptotic process
|
AKR1B1, BCL2, CSNK2A1, CYP1B1, EGFR, ESR1, F3, HSPA1A, IGF1R, KDR, MMP9, PTPN1, SMAD3, SRC, TEK, XDH |
3.28568 |
[BP] GO:0008610 |
lipid biosynthetic process
|
ACHE, AKR1B1, ALOX15, CSNK2A1, CYP19A1, CYP1A1, HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
3.24753 |
[BP] GO:0010038 |
response to metal ion
|
ALOX15, BCL2, CA2, CYP1A1, CYP1A2, EGFR, FABP4, MMP9 |
3.24753 |
[BP] GO:0031325 |
positive regulation of cellular metabolic process
|
ALOX15, BCL2, CDC25B, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, HSPA1A, IGF1R, INSR, KDR, MET, MMP9, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2, XDH |
3.20283 |
[BP] GO:0009893 |
positive regulation of metabolic process
|
ALOX15, BCL2, CDC25B, CSNK2A1, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, HSPA1A, IGF1R, INSR, KDR, MET, MMP9, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2, XDH |
3.20175 |
[BP] GO:0010604 |
positive regulation of macromolecule metabolic process
|
ALOX15, BCL2, CDC25B, CSNK2A1, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, HSPA1A, IGF1R, INSR, KDR, MET, MMP9, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2, XDH |
3.1715 |
[BP] GO:0071248 |
cellular response to metal ion
|
ALOX15, CYP1A1, CYP1A2, EGFR, FABP4, MMP9 |
3.1715 |
[BP] GO:0022414 |
reproductive process
|
AKR1B1, ALPL, BCL2, CDC25B, CYP19A1, CYP1A1, EGFR, ESR1, ESRRB, HSD11B2, HSD17B2, INSR, MMP2, MMP9, SRC |
3.1715 |
[BP] GO:0043066 |
negative regulation of apoptotic process
|
AKR1B1, BCL2, CSNK2A1, EGFR, HSPA1A, IGF1R, KDR, MMP9, PTPN1, SMAD3, SRC, TEK |
3.15756 |
[BP] GO:0048732 |
gland development
|
BCL2, CSNK2A1, CYP19A1, EGFR, INSR, SMAD3, TYR |
3.04006 |
[BP] GO:0051701 |
interaction with host
|
EGFR, HSPA1A, INSR, MET, SMAD3, SRC |
3.0224 |
[BP] GO:0006703 |
estrogen biosynthetic process
|
CYP19A1, HSD17B1, HSD17B2 |
2.99237 |
[BP] GO:0003006 |
developmental process involved in reproduction
|
ALPL, BCL2, CDC25B, CYP19A1, EGFR, ESR1, ESRRB, HSD17B2, INSR, SRC |
2.97401 |
[BP] GO:0032844 |
regulation of homeostatic process
|
BCL2, CA2, CA7, CDK6, EGFR, KDR, SRC, TNKS, TNKS2 |
2.93472 |
[BP] GO:0051247 |
positive regulation of protein metabolic process
|
ALOX15, BCL2, CDC25B, CSNK2A1, EGFR, ESR1, F3, HSPA1A, INSR, KDR, MMP9, PTPN1, SMAD3, SRC, TEK, XDH |
2.92929 |
[BP] GO:2001243 |
negative regulation of intrinsic apoptotic signaling pathway
|
BCL2, HSPA1A, MMP9, PTPN1, SRC |
2.92889 |
[BP] GO:0060065 |
uterus development
|
CYP19A1, ESR1, SRC |
2.91233 |
[BP] GO:0009115 |
None
|
AOX1, XDH |
2.91233 |
[BP] GO:0001954 |
positive regulation of cell-matrix adhesion
|
CDK6, KDR, SMAD3, TEK |
2.91233 |
[BP] GO:2000377 |
regulation of reactive oxygen species metabolic process
|
BCL2, CYP1B1, EGFR, INSR, SMAD3, XDH |
2.9021 |
[BP] GO:0001666 |
response to hypoxia
|
BCL2, CYP1A1, HSD11B2, MMP2, SMAD3, SRC, TEK |
2.90102 |
[BP] GO:0044089 |
positive regulation of cellular component biogenesis
|
ALOX15, ESR1, HSPA1A, KDR, MET, MMP1, SMAD3, SRC, TEK |
2.89831 |
[BP] GO:0071241 |
cellular response to inorganic substance
|
ALOX15, CYP1A1, CYP1A2, EGFR, FABP4, MMP9 |
2.8673 |
[BP] GO:0000302 |
response to reactive oxygen species
|
AKR1B1, BCL2, CYP1B1, EGFR, MMP9, SRC |
2.84154 |
[BP] GO:0036293 |
response to decreased oxygen levels
|
BCL2, CYP1A1, HSD11B2, MMP2, SMAD3, SRC, TEK |
2.82709 |
[BP] GO:0050790 |
regulation of catalytic activity
|
BCL2, CDC25B, CSNK2A1, DUSP3, EGFR, ESR1, F3, FABP4, HSPA1A, IGF1R, INSR, MMP9, NUAK1, PTPN1, SMAD3, SRC, TEK, TNKS, XDH |
2.82709 |
[BP] GO:0072593 |
reactive oxygen species metabolic process
|
BCL2, CYP1A1, CYP1A2, CYP1B1, EGFR |
2.82295 |
[BP] GO:0016042 |
lipid catabolic process
|
AKR1B10, CYP19A1, CYP1A2, CYP1B1, FABP3, FABP4, GBA2 |
2.80388 |
[BP] GO:0009611 |
response to wounding
|
ACHE, ALOX15, BCL2, CYP1A1, EGFR, SMAD3 |
2.79132 |
[BP] GO:0070372 |
regulation of ERK1 and ERK2 cascade
|
ALOX15, DUSP3, EGFR, KDR, PTPN1, SRC, TEK |
2.77367 |
[BP] GO:0051128 |
regulation of cellular component organization
|
ALOX15, BCL2, CSNK2A1, EGFR, ESR1, ESR2, HSPA1A, IGF1R, INSR, KDR, MET, MMP1, MMP9, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2 |
2.77057 |
[BP] GO:0010811 |
positive regulation of cell-substrate adhesion
|
ALOX15, CDK6, KDR, SMAD3, TEK |
2.76107 |
[BP] GO:0006721 |
terpenoid metabolic process
|
AKR1B10, CYP1A1, CYP1A2, CYP1B1, EGFR |
2.74394 |
[BP] GO:0042325 |
regulation of phosphorylation
|
ALOX15, BCL2, CDC25B, DUSP3, EGFR, ESRRB, FABP4, IGF1R, INSR, KDR, MMP9, PTPN1, SRC, TEK, XDH |
2.73657 |
[BP] GO:0034614 |
cellular response to reactive oxygen species
|
AKR1B1, CYP1B1, EGFR, MMP9, SRC |
2.73502 |
[BP] GO:0002009 |
morphogenesis of an epithelium
|
BCL2, CA2, EGFR, ESR1, MET, SMAD3, SRC |
2.71439 |
[BP] GO:0007346 |
regulation of mitotic cell cycle
|
BCL2, CDC25B, CDK6, CYP1A1, DUSP3, EGFR, HSPA1A, INSR, SMAD3, TNKS |
2.71286 |
[BP] GO:0016310 |
phosphorylation
|
BCL2, CDC25B, CDK6, CSNK2A1, EGFR, IGF1R, INSR, KDR, MET, NUAK1, SRC, TEK, TNKS |
2.67818 |
[BP] GO:0017144 |
drug metabolic process
|
ACHE, AKR1B1, AKR1B10, AOX1, CYP1A1, CYP1A2, CYP1B1, EGFR, HSPA1A |
2.67818 |
[BP] GO:0051893 |
regulation of focal adhesion assembly
|
KDR, SMAD3, SRC, TEK |
2.67818 |
[BP] GO:0019369 |
arachidonic acid metabolic process
|
ALOX15, CYP1A1, CYP1A2, CYP1B1 |
2.67818 |
[BP] GO:0090109 |
regulation of cell-substrate junction assembly
|
KDR, SMAD3, SRC, TEK |
2.67818 |
[BP] GO:0030155 |
regulation of cell adhesion
|
ALOX15, BCL2, CDK6, CYP1B1, DUSP3, KDR, NUAK1, SMAD3, SRC, TEK |
2.67818 |
[BP] GO:0032270 |
positive regulation of cellular protein metabolic process
|
ALOX15, BCL2, CDC25B, EGFR, ESR1, F3, HSPA1A, INSR, KDR, MMP9, PTPN1, SMAD3, SRC, TEK, XDH |
2.67818 |
[BP] GO:0048523 |
negative regulation of cellular process
|
ACHE, AKR1B1, BCL2, CDK6, CSNK2A1, CYP19A1, CYP1B1, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, GPR35, HSPA1A, IGF1R, KDR, MET, MMP9, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2, XDH |
2.67818 |
[BP] GO:0016137 |
None
|
AKR1B1, AKR1B10, GBA2 |
2.66968 |
[BP] GO:0007166 |
cell surface receptor signaling pathway
|
BCL2, CA1, CSNK2A1, EGFR, F3, GPR35, IGF1R, INSR, KDR, MET, MMP2, MMP9, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2 |
2.6629 |
[BP] GO:0042327 |
positive regulation of phosphorylation
|
ALOX15, BCL2, CDC25B, EGFR, ESRRB, INSR, KDR, MMP9, PTPN1, SRC, TEK, XDH |
2.66177 |
[BP] GO:0070482 |
response to oxygen levels
|
BCL2, CYP1A1, HSD11B2, MMP2, SMAD3, SRC, TEK |
2.66177 |
[BP] GO:0034599 |
cellular response to oxidative stress
|
AKR1B1, CYP1B1, EGFR, HSPA1A, MMP9, SRC |
2.65508 |
[BP] GO:0044093 |
positive regulation of molecular function
|
BCL2, CDC25B, EGFR, ESR1, ESR2, F3, HSPA1A, INSR, MET, MMP9, PTPN1, SMAD3, SRC, TEK, TNKS, XDH |
2.6528 |
[BP] GO:0065009 |
regulation of molecular function
|
BCL2, CDC25B, CSNK2A1, CYP1B1, DUSP3, EGFR, ESR1, ESR2, F3, FABP4, GPR35, HSPA1A, IGF1R, INSR, MET, MMP9, NUAK1, PTPN1, SMAD3, SRC, TEK, TNKS, XDH |
2.64757 |
[BP] GO:0042592 |
homeostatic process
|
AKR1B1, BCL2, CA12, CA2, CA7, EGFR, ESR1, FABP3, FABP4, GPR35, INSR, MET, SMAD3, SRC |
2.62271 |
[BP] GO:0009628 |
response to abiotic stimulus
|
AKR1B1, BCL2, CA2, CYP1A1, EGFR, HSD11B2, HSPA1A, MMP2, SMAD3, SRC, TEK, TYR |
2.61758 |
[BP] GO:0051900 |
regulation of mitochondrial depolarization
|
BCL2, KDR, SRC |
2.61758 |
[BP] GO:1903391 |
regulation of adherens junction organization
|
KDR, SMAD3, SRC, TEK |
2.61407 |
[BP] GO:0009968 |
negative regulation of signal transduction
|
BCL2, DUSP3, EGFR, ESR1, ESR2, HSPA1A, IGF1R, MET, MMP9, PTPN1, SMAD3, SRC, XDH |
2.59811 |
[BP] GO:0031399 |
regulation of protein modification process
|
ALOX15, BCL2, CDC25B, DUSP3, EGFR, FABP4, HSPA1A, IGF1R, INSR, KDR, MMP9, NUAK1, PTPN1, SRC, TEK, XDH |
2.58936 |
[BP] GO:0015711 |
organic anion transport
|
CA1, CA12, CA14, CA2, CA4, CA6, CA7, FABP3 |
2.58667 |
[BP] GO:0001932 |
regulation of protein phosphorylation
|
ALOX15, BCL2, CDC25B, DUSP3, EGFR, FABP4, IGF1R, INSR, KDR, MMP9, PTPN1, SRC, TEK, XDH |
2.57176 |
[BP] GO:0046110 |
None
|
AOX1, XDH |
2.57033 |
[BP] GO:0032849 |
positive regulation of cellular pH reduction
|
CA2, CA7 |
2.57033 |
[BP] GO:0019538 |
protein metabolic process
|
ACHE, ALPL, BCL2, CDC25B, CDK6, CSNK2A1, DUSP3, EGFR, ESR1, F10, F3, FUT7, IGF1R, INSR, KDR, MET, MMP1, MMP2, MMP9, NUAK1, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2 |
2.54664 |
[BP] GO:0043281 |
regulation of cysteine-type endopeptidase activity involved in apoptotic process
|
CSNK2A1, F3, MMP9, SMAD3, SRC, XDH |
2.54502 |
[BP] GO:0032268 |
regulation of cellular protein metabolic process
|
ALOX15, BCL2, CDC25B, CSNK2A1, DUSP3, EGFR, ESR1, F3, FABP4, HSPA1A, IGF1R, INSR, KDR, MMP9, NUAK1, PTPN1, SMAD3, SRC, TEK, XDH |
2.53 |
[BP] GO:0019373 |
epoxygenase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1 |
2.51407 |
[BP] GO:0006720 |
isoprenoid metabolic process
|
AKR1B10, CYP1A1, CYP1A2, CYP1B1, EGFR |
2.51407 |
[BP] GO:0010634 |
positive regulation of epithelial cell migration
|
KDR, MET, MMP9, SRC, TEK |
2.51407 |
[BP] GO:0043408 |
regulation of MAPK cascade
|
ALOX15, DUSP3, EGFR, IGF1R, INSR, KDR, PTPN1, SRC, TEK, XDH |
2.47701 |
[BP] GO:0051054 |
positive regulation of DNA metabolic process
|
EGFR, IGF1R, INSR, SRC, TNKS, TNKS2 |
2.4766 |
[BP] GO:0018193 |
peptidyl-amino acid modification
|
BCL2, CSNK2A1, EGFR, F10, IGF1R, INSR, KDR, MET, SRC, TEK, TNKS |
2.47369 |
[BP] GO:0030520 |
intracellular estrogen receptor signaling pathway
|
ESR1, ESR2, SRC |
2.46359 |
[BP] GO:0035239 |
tube morphogenesis
|
BCL2, EGFR, ESR1, MET, SMAD3, SRC |
2.46236 |
[BP] GO:0043401 |
steroid hormone mediated signaling pathway
|
ESR1, ESR2, ESRRA, ESRRB, SRC |
2.44925 |
[BP] GO:0001101 |
response to acid chemical
|
AKR1B1, EGFR, FABP3, HSD17B2, KDR, MMP2, SRC |
2.44766 |
[BP] GO:0048519 |
negative regulation of biological process
|
ACHE, AKR1B1, ALOX15, BCL2, CDK6, CSNK2A1, CYP19A1, CYP1B1, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, GPR35, HSPA1A, IGF1R, KDR, MET, MMP9, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2, XDH |
2.43535 |
[BP] GO:0048545 |
response to steroid hormone
|
ALPL, BCL2, CA2, EGFR, HSD11B2, SRC |
2.43001 |
[BP] GO:0009404 |
toxin metabolic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.4204 |
[BP] GO:0042493 |
response to drug
|
AKR1B1, BCL2, CDK6, CYP1A1, CYP1B1, EGFR, FABP3, HSD11B2, KDR, SRC |
2.41308 |
[BP] GO:0050678 |
None
|
CDK6, EGFR, F3, KDR, SMAD3, TEK, XDH |
2.39223 |
[BP] GO:0031334 |
positive regulation of protein complex assembly
|
ALOX15, ESR1, HSPA1A, MET, MMP1, SRC |
2.37336 |
[BP] GO:0051894 |
None
|
KDR, SMAD3, TEK |
2.37336 |
[BP] GO:1903409 |
reactive oxygen species biosynthetic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.37336 |
[BP] GO:1901701 |
cellular response to oxygen-containing compound
|
AKR1B1, CDK6, CYP1B1, EGFR, ESR1, IGF1R, INSR, MMP2, MMP9, SRC |
2.33658 |
[BP] GO:0070213 |
None
|
TNKS, TNKS2 |
2.33478 |
[BP] GO:0006145 |
None
|
AOX1, XDH |
2.33478 |
[BP] GO:0018894 |
dibenzo-p-dioxin metabolic process
|
CYP1A1, CYP1A2 |
2.33478 |
[BP] GO:0050927 |
None
|
F3, KDR, SMAD3 |
2.33244 |
[BP] GO:0044267 |
cellular protein metabolic process
|
ALPL, BCL2, CDC25B, CDK6, CSNK2A1, DUSP3, EGFR, ESR1, F10, FUT7, IGF1R, INSR, KDR, MET, MMP1, MMP2, NUAK1, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2 |
2.33095 |
[BP] GO:0010243 |
response to organonitrogen compound
|
AKR1B1, EGFR, FABP3, HSD11B2, IGF1R, INSR, MMP2, SRC, TEK, TYR |
2.31644 |
[BP] GO:0006979 |
response to oxidative stress
|
AKR1B1, BCL2, CYP1B1, EGFR, HSPA1A, MMP9, SRC |
2.31281 |
[BP] GO:0006807 |
nitrogen compound metabolic process
|
ACHE, AKR1B1, AKR1B10, ALPL, AOX1, BCL2, CDC25B, CDK6, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FUT7, GBA2, HSPA1A, IGF1R, INSR, KDR, MET, MMP1, MMP2, MMP9, NUAK1, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2, TYR, XDH |
2.31281 |
[BP] GO:0050926 |
None
|
F3, KDR, SMAD3 |
2.2915 |
[BP] GO:1903393 |
None
|
KDR, SMAD3, TEK |
2.2915 |
[BP] GO:2000116 |
regulation of cysteine-type endopeptidase activity
|
CSNK2A1, F3, MMP9, SMAD3, SRC, XDH |
2.28824 |
[BP] GO:1901652 |
response to peptide
|
AKR1B1, FABP3, HSD11B2, IGF1R, INSR, SRC, TEK |
2.27346 |
[BP] GO:1904357 |
None
|
SRC, TNKS, TNKS2 |
2.24868 |
[BP] GO:0001934 |
positive regulation of protein phosphorylation
|
ALOX15, BCL2, CDC25B, EGFR, INSR, KDR, MMP9, PTPN1, SRC, TEK, XDH |
2.24093 |
[BP] GO:0048729 |
tissue morphogenesis
|
BCL2, CA2, EGFR, ESR1, MET, SMAD3, SRC |
2.23428 |
[BP] GO:0048661 |
positive regulation of smooth muscle cell proliferation
|
AKR1B1, EGFR, MMP2, MMP9 |
2.22692 |
[BP] GO:0006464 |
cellular protein modification process
|
ALPL, BCL2, CDC25B, CDK6, CSNK2A1, DUSP3, EGFR, ESR1, F10, FUT7, IGF1R, INSR, KDR, MET, NUAK1, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2 |
2.22442 |
[BP] GO:0036211 |
protein modification process
|
ALPL, BCL2, CDC25B, CDK6, CSNK2A1, DUSP3, EGFR, ESR1, F10, FUT7, IGF1R, INSR, KDR, MET, NUAK1, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2 |
2.22442 |
[BP] GO:0051239 |
regulation of multicellular organismal process
|
BCL2, CA2, CDK6, CYP1B1, EGFR, ESR1, ESRRA, ESRRB, F3, GPR35, HSPA1A, INSR, KDR, MET, MMP9, SMAD3, SRC, TEK, TNKS2, XDH |
2.22442 |
[BP] GO:0031347 |
regulation of defense response
|
CYP19A1, EGFR, ESR1, FABP4, HSPA1A, MMP2, PTPN1, SMAD3, SRC, TEK |
2.21931 |
[BP] GO:0048869 |
cellular developmental process
|
ACHE, ALPL, BCL2, CDC25B, CDK6, CYP1A1, EGFR, ESR1, ESRRB, FABP4, FUT7, GBA2, KDR, MET, MMP2, MMP9, SMAD3, SRC, TEK |
2.19378 |
[BP] GO:0031960 |
response to corticosteroid
|
ALPL, BCL2, EGFR, HSD11B2, SRC |
2.16832 |
[BP] GO:0043696 |
None
|
CDK6, ESRRB |
2.16832 |
[BP] GO:0043697 |
None
|
CDK6, ESRRB |
2.16832 |
[BP] GO:0010641 |
None
|
F3, SRC |
2.16832 |
[BP] GO:0007598 |
None
|
F10, F3 |
2.16832 |
[BP] GO:0080135 |
regulation of cellular response to stress
|
CDK6, DUSP3, EGFR, HSPA1A, IGF1R, MET, NUAK1, PTPN1, XDH |
2.14777 |
[BP] GO:0035265 |
organ growth
|
BCL2, CYP19A1, ESR1 |
2.14777 |
[BP] GO:0042743 |
hydrogen peroxide metabolic process
|
CYP1A1, CYP1A2, EGFR |
2.14777 |
[BP] GO:2001242 |
regulation of intrinsic apoptotic signaling pathway
|
BCL2, HSPA1A, MMP9, PTPN1, SRC |
2.13938 |
[BP] GO:0051246 |
regulation of protein metabolic process
|
ALOX15, BCL2, CDC25B, CSNK2A1, DUSP3, EGFR, ESR1, F3, FABP4, HSPA1A, IGF1R, INSR, KDR, MMP9, NUAK1, PTPN1, SMAD3, SRC, TEK, XDH |
2.13789 |
[BP] GO:0033273 |
response to vitamin
|
ALPL, CYP1A1, EGFR, TYR |
2.13789 |
[BP] GO:1901888 |
regulation of cell junction assembly
|
KDR, SMAD3, SRC, TEK |
2.13789 |
[BP] GO:0008283 |
cell proliferation
|
ACHE, BCL2, CYP1A1, EGFR, ESR1, MET, SRC, TEK, TYR |
2.13403 |
[BP] GO:0051726 |
regulation of cell cycle
|
BCL2, CDC25B, CDK6, CSNK2A1, CYP1A1, DUSP3, EGFR, HSPA1A, INSR, SMAD3, SRC, TNKS |
2.13332 |
[BP] GO:0044092 |
negative regulation of molecular function
|
CSNK2A1, CYP1B1, DUSP3, ESR1, FABP4, GPR35, IGF1R, MET, MMP9, PTPN1, SRC, TNKS |
2.13332 |
[BP] GO:0043410 |
positive regulation of MAPK cascade
|
ALOX15, EGFR, INSR, KDR, PTPN1, SRC, TEK, XDH |
2.12427 |
[BP] GO:1901890 |
None
|
KDR, SMAD3, TEK |
2.12427 |
[BP] GO:0071276 |
cellular response to cadmium ion
|
CYP1A2, EGFR, MMP9 |
2.12427 |
[BP] GO:1901698 |
response to nitrogen compound
|
AKR1B1, EGFR, FABP3, HSD11B2, IGF1R, INSR, MMP2, SRC, TEK, TYR |
2.1128 |
[BP] GO:0022900 |
electron transport chain
|
AKR1B1, AOX1, CYP19A1, CYP1A2, XDH |
2.10949 |
[BP] GO:0050801 |
ion homeostasis
|
BCL2, CA12, CA2, CA7, EGFR, ESR1, FABP3, GPR35, SMAD3 |
2.07704 |
[BP] GO:0009755 |
hormone-mediated signaling pathway
|
ESR1, ESR2, ESRRA, ESRRB, SRC |
2.05274 |
[BP] GO:0010907 |
None
|
ESRRB, INSR, SRC |
2.05274 |
[BP] GO:0048608 |
reproductive structure development
|
BCL2, CYP19A1, ESR1, HSD17B2, INSR, SRC |
2.04312 |
[BP] GO:0051902 |
negative regulation of mitochondrial depolarization
|
BCL2, SRC |
2.03844 |
[BP] GO:0046113 |
None
|
AOX1, XDH |
2.03844 |
[BP] GO:0007165 |
signal transduction
|
AKR1B1, BCL2, CA1, CA2, CDK6, CSNK2A1, CYP1B1, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, GPR35, IGF1R, INSR, KDR, MET, MMP2, MMP9, NUAK1, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2 |
2.02702 |
[BP] GO:0033043 |
regulation of organelle organization
|
ALOX15, BCL2, HSPA1A, INSR, KDR, MET, MMP9, SMAD3, SRC, TEK, TNKS, TNKS2 |
2.01943 |
[BP] GO:2000379 |
positive regulation of reactive oxygen species metabolic process
|
EGFR, INSR, SMAD3, XDH |
2.0188 |
[CC] GO:0031233 |
None
|
CA4, F10, F3 |
2.5685 |
[CC] GO:0044444 |
cytoplasmic part
|
ACHE, AKR1B1, AKR1B10, ALOX15, AOX1, BCL2, CA1, CA2, CA4, CA7, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DUSP3, EGFR, ESR1, ESR2, F10, FABP3, FABP4, FUT7, GBA2, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSPA1A, INSR, KDR, MMP2, MMP9, PTPN1, SMAD3, SRC, TNKS, TNKS2, TYR, XDH |
2.43001 |
[CC] GO:0097443 |
sorting endosome
|
KDR, PTPN1 |
2.03844 |
[CC] GO:0044432 |
endoplasmic reticulum part
|
BCL2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, EGFR, F10, GBA2, HSD11B1, HSD11B2, HSD17B2, PTPN1 |
1.80631 |
[CC] GO:0005789 |
endoplasmic reticulum membrane
|
BCL2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, EGFR, GBA2, HSD11B1, HSD11B2, HSD17B2 |
1.79186 |
[MF] GO:0046914 |
transition metal ion binding
|
ALOX15, AOX1, CA1, CA12, CA2, CA4, CA6, CA7, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESR2, ESRRA, ESRRB, MMP1, MMP2, MMP9, PTPN1, SMAD3, TNKS, TYR, XDH |
11.2396 |
[MF] GO:0003824 |
catalytic activity
|
ACHE, AKR1B1, AKR1B10, ALOX15, ALPL, AOX1, CA1, CA12, CA14, CA2, CA4, CA6, CA7, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DUSP3, EGFR, F10, F3, FUT7, GBA2, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSPA1A, IGF1R, INSR, KDR, MET, MMP1, MMP2, MMP9, NUAK1, PTPN1, SRC, TEK, TNKS, TNKS2, TYR, XDH |
11.1939 |
[MF] GO:0004089 |
carbonate dehydratase activity
|
CA1, CA12, CA14, CA2, CA4, CA6, CA7 |
10.3294 |
[MF] GO:0043167 |
ion binding
|
ACHE, ALOX15, ALPL, AOX1, CA1, CA12, CA14, CA2, CA4, CA6, CA7, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, EGFR, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, HSD17B1, HSPA1A, IGF1R, INSR, KDR, MET, MMP1, MMP2, MMP9, NUAK1, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2, TYR, XDH |
8.99556 |
[MF] GO:0016836 |
hydro-lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA6, CA7 |
6.67467 |
[MF] GO:0008270 |
zinc ion binding
|
CA1, CA12, CA2, CA4, CA6, CA7, ESR1, ESR2, ESRRA, ESRRB, MMP1, MMP2, MMP9, PTPN1, SMAD3, TNKS |
6.29613 |
[MF] GO:0016835 |
carbon-oxygen lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA6, CA7 |
5.93834 |
[MF] GO:0016614 |
oxidoreductase activity, acting on CH-OH group of donors
|
AKR1B1, AKR1B10, AOX1, HSD11B1, HSD11B2, HSD17B1, HSD17B2, XDH |
5.56291 |
[MF] GO:0016491 |
oxidoreductase activity
|
AKR1B1, AKR1B10, ALOX15, AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, HSD11B1, HSD11B2, HSD17B1, HSD17B2, TYR, XDH |
5.27102 |
[MF] GO:0004714 |
transmembrane receptor protein tyrosine kinase activity
|
EGFR, IGF1R, INSR, KDR, MET, TEK |
5.03789 |
[MF] GO:0019199 |
transmembrane receptor protein kinase activity
|
EGFR, IGF1R, INSR, KDR, MET, TEK |
4.468 |
[MF] GO:0043169 |
cation binding
|
ACHE, ALOX15, ALPL, AOX1, CA1, CA12, CA14, CA2, CA4, CA6, CA7, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESR2, ESRRA, ESRRB, F10, MMP1, MMP2, MMP9, NUAK1, PTPN1, SMAD3, TNKS, TNKS2, TYR, XDH |
4.39326 |
[MF] GO:0005496 |
steroid binding
|
ESR1, ESR2, ESRRA, ESRRB, HSD11B2, HSD17B1 |
4.29617 |
[MF] GO:0046872 |
metal ion binding
|
ALOX15, ALPL, AOX1, CA1, CA12, CA14, CA2, CA4, CA6, CA7, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESR2, ESRRA, ESRRB, F10, MMP1, MMP2, MMP9, NUAK1, PTPN1, SMAD3, TNKS, TNKS2, TYR, XDH |
4.05748 |
[MF] GO:0005506 |
iron ion binding
|
ALOX15, AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, XDH |
4.01022 |
[MF] GO:0070330 |
aromatase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1 |
3.87128 |
[MF] GO:0004713 |
protein tyrosine kinase activity
|
EGFR, IGF1R, INSR, KDR, MET, SRC, TEK |
3.70377 |
[MF] GO:0016712 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1 |
3.68258 |
[MF] GO:0016829 |
lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA6, CA7 |
3.66901 |
[MF] GO:0033764 |
steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor
|
HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
3.63786 |
[MF] GO:0016616 |
oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor
|
AKR1B1, AKR1B10, HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
3.60641 |
[MF] GO:0016229 |
steroid dehydrogenase activity
|
HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
3.53582 |
[MF] GO:0004716 |
signal transducer, downstream of receptor, with protein tyrosine kinase activity
|
EGFR, INSR, KDR |
3.43968 |
[MF] GO:0008289 |
lipid binding
|
ALOX15, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, HSD11B2, HSD17B1 |
3.31028 |
[MF] GO:0042562 |
hormone binding
|
ACHE, EGFR, HSD17B1, IGF1R, INSR |
3.1371 |
[MF] GO:0016903 |
None
|
AKR1B1, AKR1B10, AOX1, XDH |
2.92889 |
[MF] GO:0004497 |
monooxygenase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, TYR |
2.92889 |
[MF] GO:0038052 |
RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding
|
ESR1, ESR2 |
2.91233 |
[MF] GO:0003845 |
None
|
HSD11B1, HSD11B2 |
2.91233 |
[MF] GO:0019825 |
oxygen binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1 |
2.91233 |
[MF] GO:0048037 |
cofactor binding
|
AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, HSD11B2, HSD17B1, SRC, XDH |
2.91094 |
[MF] GO:0098531 |
transcription factor activity, direct ligand regulated sequence-specific DNA binding
|
ESR1, ESR2, ESRRA, ESRRB |
2.79808 |
[MF] GO:0004879 |
nuclear receptor activity
|
ESR1, ESR2, ESRRA, ESRRB |
2.79808 |
[MF] GO:0004672 |
protein kinase activity
|
CDK6, CSNK2A1, EGFR, IGF1R, INSR, KDR, MET, NUAK1, SRC, TEK |
2.73657 |
[MF] GO:0009055 |
electron transfer activity
|
AKR1B1, AOX1, CYP19A1, CYP1A2, XDH |
2.73502 |
[MF] GO:0008144 |
drug binding
|
ACHE, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, EGFR, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, SRC, TEK |
2.67818 |
[MF] GO:0003707 |
steroid hormone receptor activity
|
ESR1, ESR2, ESRRA, ESRRB |
2.57033 |
[MF] GO:0020037 |
heme binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, SRC |
2.47314 |
[MF] GO:0019838 |
growth factor binding
|
EGFR, IGF1R, INSR, KDR, TEK |
2.44925 |
[MF] GO:0046906 |
tetrapyrrole binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, SRC |
2.34745 |
[MF] GO:0034056 |
estrogen response element binding
|
ESR1, ESR2 |
2.33478 |
[MF] GO:0140096 |
catalytic activity, acting on a protein
|
CDC25B, CDK6, CSNK2A1, DUSP3, EGFR, F10, F3, IGF1R, INSR, KDR, MET, MMP1, MMP2, MMP9, NUAK1, PTPN1, SRC, TEK |
2.27292 |
[MF] GO:0016773 |
phosphotransferase activity, alcohol group as acceptor
|
CDK6, CSNK2A1, EGFR, IGF1R, INSR, KDR, MET, NUAK1, SRC, TEK |
2.22592 |
[MF] GO:0032403 |
protein complex binding
|
ACHE, EGFR, ESRRB, IGF1R, INSR, KDR, MMP9, PTPN1, SMAD3, SRC |
2.19378 |
[MF] GO:0019899 |
enzyme binding
|
BCL2, CDC25B, CYP1A1, CYP1A2, DUSP3, EGFR, ESR1, ESR2, ESRRB, F3, HSPA1A, MET, PTPN1, SMAD3, SRC, TEK, TNKS2 |
2.16832 |
[MF] GO:0016705 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, TYR |
2.16832 |
[MF] GO:0030284 |
estrogen receptor activity
|
ESR1, ESR2 |
2.16832 |
[MF] GO:0043559 |
insulin binding
|
IGF1R, INSR |
2.16832 |
[MF] GO:0044877 |
macromolecular complex binding
|
ACHE, CSNK2A1, EGFR, ESRRB, IGF1R, INSR, KDR, MMP9, PTPN1, SMAD3, SRC |
2.1265 |
[MF] GO:0005158 |
None
|
IGF1R, PTPN1, SRC |
2.12427 |
[MF] GO:0019902 |
phosphatase binding
|
BCL2, EGFR, MET, PTPN1, SMAD3 |
2.08598 |
[MF] GO:0043168 |
anion binding
|
ALOX15, AOX1, CDK6, CSNK2A1, EGFR, F10, F3, FABP3, FABP4, HSD17B1, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, SRC, TEK, XDH |
2.05274 |
[MF] GO:0004064 |
arylesterase activity
|
CA1, CA2 |
2.03844 |
[MF] GO:0043546 |
None
|
AOX1, XDH |
2.03844 |